F20 F21 F25 F31.5 F33.3
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - not pregnant - medical indication for continuous antipsychotic treatment for at least 6 month, - normal physical examination including ECG, - no history of any neurological impairment, - not currently taking medication for any cardiovascular or pulmonary conditions - no dependency on alcohol or narcotic drugs, including benzodiazepines, - able to perform isometric strength measurements and a submaximal exercise test to the aerobic-anaerobic threshold via lactate kinetics without health complications, - able to read and write in German, - free from infections (e. g., cold, flu, Covid-19) the week prior to testing and on the days of testing, - in possession of an email address and phone number for contacting purposes.
Exclusion criteria
Exclusion criteria: - pregnant - medical indication for continuous antipsychotic treatment for less than 6 month, - abnormal physical examination including ECG, - history of any neurological impairment, - currently taking medication for any cardiovascular or pulmonary conditions - dependency on alcohol or narcotic drugs, including benzodiazepines, - not able to perform isometric strength measurements and a submaximal exercise test to the aerobic-anaerobic threshold via lactate kinetics without health complications, - not able to read and write in German, - not free from infections (e. g., cold, flu, Covid-19) the week prior to testing and on the days of testing, - no email address and phone number for contacting purposes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the physical fitness, being assessed at the beginning and end (after three month) of the study, by using an incremental bicycle test and lactate measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondaray endpoints are i) body composition, ii) blood lipids, iii) HbA1c-value, iv) psychometric evaluation, v) physical activity and vi) nutrition. All these parameters will be assessed at the beginning and end (after three month) of the study, by i) air displacement plethysomgraphy, ii-iii) blood laboratory tests, iv-vi) questionnaires and standardized interviews. | — |
Countries
Germany
Contacts
Psychiatrie und Psychotherapie, Universität zu Lübeck